-
Regulus Therapeutics' (RGLS) "Buy" Rating Reaffirmed at HC Wainwright
Источник: Buzz FX / 15 мар 2025 07:16:17 America/Chicago
Regulus Therapeutics' (RGLS) "Buy" Rating Reaffirmed at HC Wainwright Written by MarketBeat March 15, 2025 Share Link copied to clipboard. Remove Ads Regulus Therapeutics ( NASDAQ:RGLS - Get Free Report ) 's stock had its "buy" rating reiss
Read more...